Bioactivity | Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells[1]. |
Name | Davoceticept |
CAS | 2307144-64-3 |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Davoceticept. IMGT. |